Micromagnetic-microfluidic device could quickly pull pathogens from the bloodstream

Mar 25, 2009

Sepsis, an infection of the blood, can quickly overwhelm the body's defenses and is responsible for more than 200,000 deaths per year in the U.S. alone. Premature newborns and people with weakened immune systems are especially vulnerable. Since most existing treatments are ineffective, researchers in the Vascular Biology Program at Children's Hospital Boston have come up with a first line of defense -- using magnetism to quickly pull pathogens out of the blood.

Their blood-cleansing device, developed by Chong Wing Yung, PhD, a researcher in the laboratory of Don Ingber, MD, PhD, is described in the journal .

The system they envision will work like this: The patient's is drawn, and tiny , pre-coated with antibodies against specific (such as the fungus Candida albicans) are added. The blood is then run through a in which two liquid flow streams run side by side without mixing -- one containing blood, the other a saline-based collection fluid. The beads bind to the pathogens, and a magnet then pulls them (along with the pathogens) into the collection fluid, which is ultimately discarded, while the cleansed blood in reintroduced into the patient.

Tested with contaminated human blood, a device with four parallel collection modules achieved over 80 percent clearance of fungi in a single pass, at a flow rate and separation efficiency that would be viable for clinical applications. Yung and Ingber estimate that a scaled-up system with hundreds of channels could cleanse the blood of an infant within several hours.

"This blood-cleansing microdevice offers a potentially new weapon to fight pathogens in septic infants and adults, that works simply by removing the source of the infection and thereby enhancing the patient's response to existing antibiotics," says Ingber.

More information: The article can be accessed at http://www.rsc.org/publishing/journals/LC/article.asp?doi=B816986A, and is scheduled for formal online publication on April 13.

Source: Children's Hospital Boston

Explore further: Following a protein's travel inside cells is key to improving patient monitoring, drug development

add to favorites email to friend print save as pdf

Related Stories

White blood cells are picky about sugar

Jul 11, 2007

Biology textbooks are blunt—neutrophils are mindless killers. These white blood cells patrol the body and guard against infection by bacteria and fungi, identifying and destroying any invaders that cross ...

An 'attractive' man-machine interface

Jan 09, 2008

Researchers at Children’s Hospital Boston have developed a new “nanobiotechnology” that enables magnetic control of events at the cellular level. They describe the technology, which could lead to finely-tuned but noninvasive ...

Recommended for you

The anti-inflammatory factory

Apr 22, 2014

Russian scientists, in collaboration with their colleagues from Pittsburgh University, have discovered how lipid mediators are produced. The relevant paper was published in Nature Chemistry. Lipid mediators are molecules that p ...

User comments : 0

More news stories